![Krishna Ella's Sapigen, Science Ministry partner for malaria, Covid-19 nasal vaccine](https://images.assettype.com/fortuneindia%2F2022-03%2Fe57a8d9f-3c80-48fe-a012-cc842b577719%2FF_Dr_Krishna_Ella_CMD_Bharat_Biotech_2_copy.jpg?rect=0,0,2048,1024&w=300&q=95)
Krishna Ella's Sapigen, Science Ministry partner for malaria, Covid-19 nasal vaccine
Technology Development Board and Bharat Biotech will put in ₹200 crore each to create a continuous corpus of ₹400 crore for the partnership project.
Technology Development Board and Bharat Biotech will put in ₹200 crore each to create a continuous corpus of ₹400 crore for the partnership project.
GSK to make 15 million annual doses, transfer technology to Hyderabad-based firm for long-term antigen production